What does the public think about rescheduling cannabis in a post-prohibition era driven by data, not stigma. What does the public think about rescheduling cannabis? Long before federal officials formally moved to reschedule cannabis, they  had already made up their mind. According to a widely cited poll from Pew Research Center, 88% of Americans supported legal cannabis in some form—either for medical use, adult use, or both—prior to the rescheduling announcement. The overwhelming consensus set the stage for what many see as a long-overdue policy shift catching up with reality. Post-rescheduling polling shows public opinion has only grown more confident, particularly around cannabis’s medical potential. A December 2025 survey from YouGov found more than three-quarters of U.S. adults believe cannabis has legitimate medical uses, while just a small minority disagreed. Notably, the poll also showed broad approval for rescheduling specifically because it allows expanded medical research—an issue which resonates across party lines.

Another YouGov medical-focused poll reinforces the point. Large majorities said cannabis should be studied and made available as a treatment option, especially where conventional therapies fall short. This is not abstract support; it reflects lived experience. Veterans coping with PTSD consistently report medical cannabis can help manage anxiety, nightmares, and sleep disruption when traditional medications fail or cause harsh side effects. For many, rescheduling represents validation rather than experimentation. Patients with cancer, IBS, and chronic pain echo similar sentiments. Poll respondents frequently cite cannabis’s ability to ease nausea from chemotherapy, stimulate appetite, reduce inflammation, and improve sleep quality. Sleep, in particular, stands out as a near-universal concern—one where many Americans say cannabis has helped them fall asleep faster and stay asleep longer. The impact extends beyond people. Everyday pet owners increasingly report using CBD products to calm anxious dogs during fireworks, ease joint pain in aging pets, and improve overall quality of life. While veterinarians urge careful dosing and further study, public acceptance of pet-focused CBD mirrors the broader shift toward viewing cannabis as a wellness tool rather than a cultural wedge issue. Taken together, these polls paint a clear picture. Americans are not debating whether cannabis belongs in modern medicine—they are asking how best to regulate, research, and responsibly use it. Rescheduling did not change public opinion; it aligned federal policy with a public already convinced cannabis can help real people, and even their pets, live better lives.

The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit www.thefreshtoast.com.

The Fresh Toast